Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-20

Study Completion Date

2024-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to learn if using a lay VA volunteer, who will assist patients with education regarding precision medicine, can improve care quality and outcomes for Veteran patients with lung cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Engagement of Veterans With Lung Cancer

NCT07219251

Lung Cancer (NSCLC) Lung Adenocarcinoma Lung Cancer, Non-Small Cell +3 more

NOT_YET_RECRUITING NA

Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions

NCT02899754

Lung Cancer Screening

COMPLETED NA

Centralized Lung Cancer Screening Engagement in At-Risk Populations

NCT07216144

Lung Cancer Screening

ENROLLING_BY_INVITATION NA

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

NCT05747443

Lung Cancer Lung Cancer Screening

ACTIVE_NOT_RECRUITING NA

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

NCT02190864

Particularly Rural/Urban Residence Gender Age +2 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants in the intervention group will receive 1:1 communication with a lay VA volunteer in addition to their usual clinical care. The lay VA volunteer will provide patients with education about precision medicine and support in their care. Researchers will compare a control group who will receive their usual oncology care as provided by clinical teams at the VA. There will be no change in their care.

All participants will be asked to complete a survey at the time of enrollment in the study, and also at 1 month. This survey will measure patient participation in their cancer care, satisfaction with healthcare decisions, and overall questions about knowledge of precision medicine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Participants randomized to this arm of the study will receive usual care with supplemental education and support provided by a lay VA volunteer trained on evidence-based lung cancer care.

Group Type EXPERIMENTAL

Receive education on precision medicine

Intervention Type BEHAVIORAL

Patients who consent to participating in the study and are randomized to the intervention group, will meet 1 on 1 with a trained lay VA volunteer. The trained lay VA volunteer will conduct phone calls with patients until the end of the 1 month enrollment period to deliver education regarding precision medicine.

Control

Participants randomized to this arm of the study will receive usual clinical care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Receive education on precision medicine

Patients who consent to participating in the study and are randomized to the intervention group, will meet 1 on 1 with a trained lay VA volunteer. The trained lay VA volunteer will conduct phone calls with patients until the end of the 1 month enrollment period to deliver education regarding precision medicine.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients 18 years old that have been newly diagnosed with any stage of lung cancer.
* Patients must have the ability to understand and willingness to provide verbal consent.
* Participants must speak English.

Exclusion Criteria

* Inability to consent to the study, severe mental illness (e.g. schizophrenia) or institutionalization.
* Patients who anticipate moving care outside the Veterans Affairs Palo Alto Health Care System within 6 months.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No